Glutamatergic pathway targeting in melanoma: single-agent and combinatorial therapies. [electronic resource]
Producer: 20120325Description: 7080-92 p. digitalISSN:- 1557-3265
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Benzenesulfonates -- administration & dosage
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Glutamic Acid -- metabolism
- Indoles -- administration & dosage
- Melanoma -- drug therapy
- Mice
- Mice, Nude
- Molecular Targeted Therapy
- Mutation
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Proto-Oncogene Proteins B-raf -- antagonists & inhibitors
- Pyridines -- administration & dosage
- Receptors, Metabotropic Glutamate -- antagonists & inhibitors
- Riluzole -- administration & dosage
- Signal Transduction -- drug effects
- Sorafenib
- Sulfonamides -- administration & dosage
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.